Skip to main content
. 2014 Dec 1;28(23):2652–2662. doi: 10.1101/gad.250936.114

Figure 4.

Figure 4.

Mutational analysis of the CXC domain. (A) Titration of CXC mutants with S12 DNA. Selected regions of HSQC spectra are shown. (B) Immunofluorescence analysis of the X chromosomal territories in S2 cell lines stably expressing MSL2-GFP or its R543A mutant using antibodies against GFP and MSL3. Arrowheads indicate compact normal X territories. Unmarked GFP-expressing cells lack a distinct chromosomal territory and show delocalized MSL2-GFP and endogenous MSL3. The percentage of cells that show such defects is displayed at the right. (C) ChIP assays on S2 cells (CTRL) or stable cell lines expressing MSL2-GFP or its mutants (R543A, R526A, and N534A). The binding of MSL2 or one of the mutants to three high-affinity sites (CES11D1, roX1, and Set2-H) or to a control locus that has no MRE sequences (Set2-1) from two independent biological replicates is shown side by side and expressed as percentage of input.